| Date Filed | Type | Description |
| 08/25/2023 |
3
| ZAVRL FRANK (Director) has filed a Form 3 on CervoMed Inc. |
| 08/24/2023 |
3
| Sabbagh Marwan (Director) has filed a Form 3 on CervoMed Inc. |
| 08/23/2023 |
3
| Blackburn Kelly (VP, Clinical Development) has filed a Form 3 on CervoMed Inc. |
| 08/23/2023 |
3
| ALAM JOHN J (CEO and President) has filed a Form 3 on CervoMed Inc. |
| 08/23/2023 |
3
| Gregoire Sylvie (10% Owner) has filed a Form 3 on CervoMed Inc. |
| 08/23/2023 |
3
| Poulton Jeffrey V. (Director) has filed a Form 3 on CervoMed Inc. |
| 08/23/2023 |
3
| TANNER JOHN WILLIAM (CFO) has filed a Form 3 on CervoMed Inc. |
| 08/11/2023 |
3
| DAVIDSON JILL (Director) has filed a Form 3 on Diffusion Pharmaceuticals Inc. |
| 07/05/2023 |
4
| LANCHONEY DIANA M (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Disposed/sold 85 shares
@ $0
Exercised 232 restricted stock units
@ $0 |
|
| 06/02/2023 |
4
| Hollingsworth Jane H (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Disposed/sold 68 shares
@ $0
Exercised 183 restricted stock units
@ $0 |
|
| 04/03/2023 |
4
| LANCHONEY DIANA M (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Disposed/sold 85 shares
@ $0
Exercised 232 restricted stock units
@ $0 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2022 |
4
| Hollingsworth Jane H (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Disposed/sold 67 shares
@ $0
Exercised 183 restricted stock units
@ $0 |
|
| 08/26/2022 |
4
| JAEGER RAVEN (Chief Regulatory Officer) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Granted 8,000 options to buy
@ $7.75, valued at
$62k
|
|
| 08/26/2022 |
3
| JAEGER RAVEN (Chief Regulatory Officer) has filed a Form 3 on Diffusion Pharmaceuticals Inc. |
| 08/03/2022 |
4
| Cobuzzi Robert Joseph Jr. (President & CEO) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Disposed/sold 121 shares
@ $0
Exercised 327 restricted stock units
@ $0 |
|
| 06/02/2022 |
4
| Hollingsworth Jane H (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Disposed/sold 67 shares
@ $0
Exercised 183 restricted stock units
@ $0 |
|
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2022 |
4
| Cobuzzi Robert Joseph Jr. (President & CEO) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Converted 100 shares
@ $25, valued at
$2.5k
Converted 100 options to buy
@ $25, valued at
$2.5k
|
|
| 04/19/2022 |
4
| ELDER WILLIAM ROBERT (GC & Secretary) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Converted 100 shares
@ $25, valued at
$2.5k
Converted 100 options to buy
@ $25, valued at
$2.5k
|
|
| 03/22/2022 |
4
| ELDER WILLIAM ROBERT (GC & Secretary) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Bought 5,000 options to buy
@ $0.5, valued at
$2.5k
|
|
| 03/22/2022 |
4
| Cobuzzi Robert Joseph Jr. (President & CEO) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Bought 5,000 options to buy
@ $0.5, valued at
$2.5k
|
|
| 02/02/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| Hornung William Karl (CFO) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Granted 305,743 options to buy
@ $0.24, valued at
$73.4k
|
|
| 01/31/2022 |
4
| GALLOWAY CHRISTOPHER D (Chief Medical Officer) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Granted 305,743 options to buy
@ $0.24, valued at
$73.4k
|
|
| 01/31/2022 |
4
| ELDER WILLIAM ROBERT (GC & Secretary) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Granted 305,743 options to buy
@ $0.24, valued at
$73.4k
|
|
| 01/31/2022 |
4
| Cobuzzi Robert Joseph Jr. (President & CEO) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Granted 764,357 options to buy
@ $0.24, valued at
$183.4k
|
|
| 11/03/2021 |
4
| Cobuzzi Robert Joseph Jr. (President & CEO) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Exercised 16,350 restricted stock units
@ $0 |
|
| 10/15/2021 |
4
| LANCHONEY DIANA M (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Granted 83,300 options to buy
@ $0.72, valued at
$60k
Granted 69,400 restricted stock units
@ $0 |
|
| 10/15/2021 |
3
| LANCHONEY DIANA M (Director) has filed a Form 3 on Diffusion Pharmaceuticals Inc. |
| 10/15/2021 |
3
| Francois Eric (Director) has filed a Form 3 on Diffusion Pharmaceuticals Inc. |
|